Mira Pavlovic

PRE-MARKET CLINICAL EVALUATIONS OF INNOVATIVE HIGH-RISK MEDICAL DEVICES IN EUROPE

Frank Hulstaert, Mattias Neyt, Imgard Vinck et al. · International Journal of Technology Assessment in Health Care · 2012 · 49 citations · Full text

Pharmacy, Pharmaceutical Policy, Clinical Trial Regulation +16

Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment

Michael Berntgen, Anne Gourvil, Mira Pavlovic et al. · Value in Health · 2014 · 47 citations

Pharmacy, Health Policy, Pharmaceutical Policy +10

Treatment of early AIDS-related Kaposiʼs sarcoma with oral all-trans-retinoic acid

Philippe Saïag, Mira Pavlovic, T. Clérici et al. · AIDS · 1998 · 42 citations

Medicine, Oncology, Pharmacology +12

The role of stakeholder involvement in the evolving EU HTA process: <i>Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire</i>

Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet et al. · Journal of Market Access & Health Policy · 2023 · 15 citations · Full text

Management, Health Policy, Regulatory Policy +16

ENDPOINTS FOR RELATIVE EFFECTIVENESS ASSESSMENT (REA) OF PHARMACEUTICALS

Mira Pavlovic, Conor Teljeur, Beate Wieseler et al. · International Journal of Technology Assessment in Health Care · 2014 · 13 citations

Pharmacy, Pharmacotherapy, Comparative Effectiveness Research +16